These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 22530301)

  • 1. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
    Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
    Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
    Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance.
    Schamp K; Schreder SA; Dressman J
    Eur J Pharm Biopharm; 2006 Apr; 62(3):227-34. PubMed ID: 16246538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of lipid matrix aging on in vitro release and in vivo bioavailability.
    Choy YW; Khan N; Yuen KH
    Int J Pharm; 2005 Aug; 299(1-2):55-64. PubMed ID: 15955645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etodolac-liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulation.
    Barakat NS
    Drug Dev Ind Pharm; 2006 Aug; 32(7):865-76. PubMed ID: 16908424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000.
    Dang YJ; Hu CH; An LN; Zhu CY
    Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):157-62. PubMed ID: 20448857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.
    Wu W; Wang Y; Que L
    Eur J Pharm Biopharm; 2006 Jul; 63(3):288-94. PubMed ID: 16527467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol.
    Soliman MS; Khan MA
    Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing bioavailability of silymarin.
    Javed S; Kohli K; Ali M
    Altern Med Rev; 2011 Sep; 16(3):239-49. PubMed ID: 21951025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.
    Lian R; Lu Y; Qi J; Tan Y; Niu M; Guan P; Hu F; Wu W
    AAPS PharmSciTech; 2011 Dec; 12(4):1234-40. PubMed ID: 21948306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
    Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
    Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.
    Sinha S; Ali M; Baboota S; Ahuja A; Kumar A; Ali J
    AAPS PharmSciTech; 2010 Jun; 11(2):518-27. PubMed ID: 20238187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
    Sun Y; Rui Y; Wenliang Z; Tang X
    Int J Pharm; 2008 Jul; 359(1-2):144-9. PubMed ID: 18499371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.